CSF2 and colitis: Oral enoxaparin treatment in experimental colitis reduced numbers of M1 macrophages and elevated numbers of M2 macrophages assumingly by reducing levels of Granulocyte-macrophage colony-stimulating factor (GM-CSF), which contributes in the differentiation of monocytes into pro-inflammatory macrophages during intestinal inflammation (Lean, et al., 2015b).